Philippe Desjeux. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntiprotozoal Agents/pharmacologyAntiprotozoal Agents/therapeutic useHumansInsect Control/methodsLeishmania/drug effectsLeishmania/geneticsLeishmaniasis/diagnosisLeishmaniasis/drug therapyLeishmaniasis/epidemiologyLeishmaniasis/parasitologyParomomycin/pharmacologyParomomycin/therapeutic usePhosphorylcholine/analogs & derivativesPhosphorylcholine/pharmacologyPhosphorylcholine/therapeutic useProtozoan Vaccines
Substances: See more » Antiprotozoal AgentsProtozoan VaccinesPhosphorylcholinemiltefosineParomomycin
Year: 2004 PMID: 15378809 DOI: 10.1038/nrmicro981
Source DB: PubMed Journal: Nat Rev Microbiol ISSN: 1740-1526 Impact factor: 60.633